Biomedical Engineering Reference
In-Depth Information
Venalainen JI, Juvonen RO, Mannisto PT (2004) Evolutionary relationships of the prolyl oli-
gopeptidase family enzymes. Eur J Biochem 271(13):2705-2715. doi:10.1111/j.1432-
1033.2004.04199.x
Vesely DL, Giordano AT (1991) Atrial natriuretic peptide hormonal system in plants. Biochem
Biophys Res Commun 179(1):695-700
Vilotti S, Marchenkova A, Ntamati N, Nistri A (2013) B-Type Natriuretic Peptide-Induced De-
layed Modulation of TRPV1 and P2X3 Receptors of Mouse Trigeminal Sensory Neurons. PloS
one 8(11):e81138. doi:10.1371/journal.pone.0081138
Vincent PA, Delgado MA, Farias RN, Salomon RA (2004) Inhibition of
Salmonella enterica
serovars
by microcin J25. FEMS Microbiol Lett 236(1):103-107. doi:10.1016/j.femsle.2004.05.027
Vincent PA, Bellomio A, de Arcuri BF, Farías RN, Morero RD (2005) MccJ25 C-terminal is in-
volved in RNA-polymerase inhibition but not in respiration inhibition. Biochem Biophys Res
Commun 331(2):549-551
Vincent PA, Morero RD (2009) The structure and biological aspects of peptide antibiotic microcin
J25. Curr Med Chem 16(5):538-549
von Geldern TW, Budzik GP, Dillon TP, Holleman WH, Holst MA, Kiso Y, Novosad EI, Op-
genorth TJ, Rockway TW, Thomas AM, et al. (1990) Atrial natriuretic peptide antagonists:
biological evaluation and structural correlations. Mol Pharmacol 38(6):771-778
Wakelam MJ, Murphy GJ, Hruby VJ, Houslay MD (1986) Activation of two signal-transduction
systems in hepatocytes by glucagon. Nature 323(6083):68-71. doi:10.1038/323068a0
Wallace BA, Janes RW, Bassolino DA, Krystek SR Jr (1995) A comparison of X-ray and NMR
structures for human endothelin-1. Protein Sci 4(1):75-83. doi:10.1002/pro.5560040110
Weber W, Fischli W, Hochuli E, Kupfer E, Weibel EK (1991) Anantin-a peptide antagonist of the
atrial natriuretic factor (ANF). I. Producing organism, fermentation, isolation and biological
activity. J Antibiot 44(2):164-171
Wilen CB, Tilton JC, Doms RW (2012a) HIV: cell binding and entry. Cold Spring Harb Perspect
Med 2(8). doi:10.1101/cshperspect.a006866
Wilen CB, Tilton JC, Doms RW (2012b) Molecular mechanisms of HIV entry. Adv Exp Med Biol
726:223-242. doi:10.1007/978-1-4614-0980-9_10
Wilk S, Orlowski M (1983) Inhibition of rabbit brain prolyl endopeptidase by n-benzyloxycarbon-
yl-prolyl-prolinal, a transition state aldehyde inhibitor. J Neurochem 41(1):69-75
Williams RS (2005) Pharmacogenetics in model systems: defining a common mechanism of ac-
tion for mood stabilisers. Prog Neuropsychopharmacol Biol Psychiatry 29(6):1029-1037.
doi:10.1016/j.pnpbp.2005.03.020
Williams DL Jr, Jones KL, Pettibone DJ, Lis EV, Clineschmidt BV (1991) Sarafotoxin S6c: an
agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res
Commun 175(2):556-561
Williams RS, Eames M, Ryves WJ, Viggars J, Harwood AJ (1999) Loss of a prolyl oligopep-
tidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate. EMBO J
18(10):2734-2745. doi:10.1093/emboj/18.10.2734
Wilson KA, Kalkum M, Ottesen J, Yuzenkova J, Chait BT, Landick R, Muir T, Severinov K, Darst
SA (2003) Structure of microcin J25, a peptide inhibitor of bacterial RNA polymerase, is a las-
soed tail. J Am Chem Soc 125(41):12475-12483
Xing J, Moldobaeva N, Birukova AA (1985) Atrial natriuretic peptide protects against
Staphy-
lococcus
aureus
-induced lung injury and endothelial barrier dysfunction. J Appl Physiol
110(1):213-224
Yamaguchi T, Murata Y, Fujiyoshi Y, Doi T (2003) Regulated interaction of endothelin B receptor
with caveolin-1. Eur J Biochem 270(8):1816-1827
Yanagisawa M, Masaki T (1989) Molecular biology and biochemistry of the endothelins. Trends
Pharmacol Sci 10(9):374-378
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K,
Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells.
Nature 332(6163):411-415. doi:10.1038/332411a0
Search WWH ::
Custom Search